88 related articles for article (PubMed ID: 20704797)
21. Hepatic progenitor cells in liver cancers from Asian children.
Ward SC; Thung SN; Lim KH; Tran TT; Hong TK; Hoang PL; Jang JJ; Park YN; Abe K
Liver Int; 2010 Jan; 30(1):102-11. PubMed ID: 19793197
[TBL] [Abstract][Full Text] [Related]
22. High expression of telomerase is an independent prognostic indicator of poor outcome in hepatoblastoma.
Hiyama E; Yamaoka H; Matsunaga T; Hayashi Y; Ando H; Suita S; Horie H; Kaneko M; Sasaki F; Hashizume K; Nakagawara A; Ohnuma N; Yokoyama T
Br J Cancer; 2004 Aug; 91(5):972-9. PubMed ID: 15280920
[TBL] [Abstract][Full Text] [Related]
23. A Brief Report of Immunohistochemical Markers to Identify Aggressive Hepatoblastoma.
Singh V; Manalang M; Singh M; Apte U
Appl Immunohistochem Mol Morphol; 2018 Oct; 26(9):654-657. PubMed ID: 28187036
[TBL] [Abstract][Full Text] [Related]
24. Hepatoblastoma.
Stocker JT
Semin Diagn Pathol; 1994 May; 11(2):136-43. PubMed ID: 7809507
[TBL] [Abstract][Full Text] [Related]
25. Surgical management of intrahepatic vessels in children with stage III/IV hepatoblastoma.
Pang YL; Zhao W; Yang HY; Liu QL; Zhang D; Qin P; Yue M; Wang L; Zhang JJ; Wang JX
Chin Med J (Engl); 2013; 126(11):2134-8. PubMed ID: 23769572
[TBL] [Abstract][Full Text] [Related]
26. [Glypican 3 expression in hepatoblastoma and its diagnostic implication].
Wang FH; Wen JM; Vong HT; Yip YC
Zhonghua Bing Li Xue Za Zhi; 2013 Dec; 42(12):806-9. PubMed ID: 24507097
[TBL] [Abstract][Full Text] [Related]
27. Predictive value of the pretreatment extent of disease system in hepatoblastoma: results from the International Society of Pediatric Oncology Liver Tumor Study Group SIOPEL-1 study.
Aronson DC; Schnater JM; Staalman CR; Weverling GJ; Plaschkes J; Perilongo G; Brown J; Phillips A; Otte JB; Czauderna P; MacKinlay G; Vos A
J Clin Oncol; 2005 Feb; 23(6):1245-52. PubMed ID: 15718322
[TBL] [Abstract][Full Text] [Related]
28. Ethanol-responsive genes in neural cells include the 78-kilodalton glucose-regulated protein (GRP78) and 94-kilodalton glucose-regulated protein (GRP94) molecular chaperones.
Miles MF; Wilke N; Elliot M; Tanner W; Shah S
Mol Pharmacol; 1994 Nov; 46(5):873-9. PubMed ID: 7969074
[TBL] [Abstract][Full Text] [Related]
29. Multidisciplinary management of hepatoblastoma in children: Experience from a developing country.
Shanmugam N; Scott JX; Kumar V; Vij M; Ramachandran P; Narasimhan G; Reddy MS; Kota V; Munirathnam D; Kelgeri C; Sundaram K; Rela M
Pediatr Blood Cancer; 2017 Mar; 64(3):. PubMed ID: 27781375
[TBL] [Abstract][Full Text] [Related]
30. The diagnostic and prognostic value of SALL4 in hepatoblastoma.
Zhou S; Venkatramani R; Gomulia E; Shillingford N; Wang L
Histopathology; 2016 Nov; 69(5):822-830. PubMed ID: 27252091
[TBL] [Abstract][Full Text] [Related]
31. Stages of normal and aberrant intrahepatic bile duct development in a mixed hepatoblastoma.
Libbrecht L; Desmet V; Roskams T
Histopathology; 2003 Jun; 42(6):618-20. PubMed ID: 12786902
[No Abstract] [Full Text] [Related]
32. Detection of Serum Protein Biomarkers for the Diagnosis and Staging of Hepatoblastoma.
Zhao W; Li J; Zhang J; Gao P; Pei H; Wang L; Guo F; Yu J; Zheng S; Wang J
Int J Mol Sci; 2015 Jun; 16(6):12669-85. PubMed ID: 26053398
[TBL] [Abstract][Full Text] [Related]
33. The influence of preoperative chemotherapy and surgical technique in the treatment of hepatoblastoma--a report from the German Cooperative Liver Tumour Studies HB 89 and HB 94.
Fuchs J; Rydzynski J; Hecker H; Mildenberger H; Bürger D; Harms D; V Schweinitz D;
Eur J Pediatr Surg; 2002 Aug; 12(4):255-61. PubMed ID: 12369004
[TBL] [Abstract][Full Text] [Related]
34. Transcription factor FOXA3 promotes the development of Hepatoblastoma via regulating HNF1A, AFP, and ZFHX3 expression.
Zhan X; Zhao A
J Clin Lab Anal; 2021 Mar; 35(3):e23686. PubMed ID: 33368532
[TBL] [Abstract][Full Text] [Related]
35. Lead induces the expression of endoplasmic reticulum chaperones GRP78 and GRP94 in vascular endothelial cells via the JNK-AP-1 pathway.
Shinkai Y; Yamamoto C; Kaji T
Toxicol Sci; 2010 Apr; 114(2):378-86. PubMed ID: 20071421
[TBL] [Abstract][Full Text] [Related]
36. Treatment of unresectable and metastatic hepatoblastoma: a pediatric oncology group phase II study.
Katzenstein HM; London WB; Douglass EC; Reynolds M; Plaschkes J; Finegold MJ; Bowman LC
J Clin Oncol; 2002 Aug; 20(16):3438-44. PubMed ID: 12177104
[TBL] [Abstract][Full Text] [Related]
37. Pediatric liver transplantation for hepatoblastoma: a single center experience.
Kim T; Kim DY; Kim KM; Seo JJ; Park KM; Lee YJ; Lee SG
Transplant Proc; 2012 Mar; 44(2):523-5. PubMed ID: 22410061
[TBL] [Abstract][Full Text] [Related]
38. Randomized comparison of cisplatin/vincristine/fluorouracil and cisplatin/continuous infusion doxorubicin for treatment of pediatric hepatoblastoma: A report from the Children's Cancer Group and the Pediatric Oncology Group.
Ortega JA; Douglass EC; Feusner JH; Reynolds M; Quinn JJ; Finegold MJ; Haas JE; King DR; Liu-Mares W; Sensel MG; Krailo MD
J Clin Oncol; 2000 Jul; 18(14):2665-75. PubMed ID: 10894865
[TBL] [Abstract][Full Text] [Related]
39. Extreme hepatic resections for the treatment of advanced hepatoblastoma: Are planned close margins an acceptable approach?
Fonseca A; Gupta A; Shaikh F; Ramphal R; Ng V; McGilvray I; Gerstle JT
Pediatr Blood Cancer; 2018 Feb; 65(2):. PubMed ID: 28921939
[TBL] [Abstract][Full Text] [Related]
40. Hepatoblastoma in a dog.
Shiga A; Shirota K; Shida T; Yamada T; Nomura Y
J Vet Med Sci; 1997 Dec; 59(12):1167-70. PubMed ID: 9450251
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
